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Abstract
Molecular beacons (MBs) are oligonucleotide probes with a hairpin-like structure that are typically labelled
at the 50 and 30 ends with a fluorophore and a quencher dye, respectively. The conformation of the MB acts
as a switch for fluorescence emission. When the fluorophore is in close proximity to the quencher,
fluorescence emission cannot be detected, meaning that the switch is in an OFF state. However, if the
MB structure is modified, separating the fluorophore from the quencher, the switch turns ON allowing
fluorescence emission. This property has been extensively used for a wide variety of applications including
real-time PCR reactions, study of protein-DNA interactions, and identification of conformational changes
in RNA structures. Here, we describe a protocol based on the MB technology to measure the RNA
unfolding capacities of the CspA RNA chaperone from Staphylococcus aureus. This method, with slight
variations, may also be applied for testing the activity of other RNA chaperones, RNA helicases, or
ribonucleases.
Key words RNA, Chaperone, RNA-binding protein, Hairpin, Stem loop, Molecular beacon,
Fluorescein, Quencher, FAM
1 Introduction
Molecular beacons (MBs) are oligonucleotide probes commonly
used to target DNA for real-time monitoring of polymerase chain
reactions (RT-PCRs). The central nucleotides of the MB are com-
plementary to a specific DNA (or RNA) target and do not base pair
with one another, while the five to seven nucleotides at each termi-
nus are complementary to each other, creating a hairpin-like con-
formation (Fig. 1a). Since the 50 and 30 ends are labelled with a
fluorophore and a quencher, respectively, the MB acts as a switch.
In their native conformation, the extremes are close enough for the
quencher to prevent fluorescent emission from the fluorophore
(switch OFF). When the MB hybridizes with its specific target, its
native structure is disrupted, and both dye molecules fall apart from
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each other, allowing fluorescence emission (switch ON) (Fig. 1a).
Since MBs tolerate very versatile designs, they have been used for
various applications [1, 2]. Molecular biologists have taken advan-
tage of their potential for studying different mechanisms such as
protein-DNA interactions [3], single-stranded DNA cleavage by
specific nucleases (Fig. 1b) [4], and structural changes on ribo-
zymes and riboswitches (Fig. 1c) [5, 6]. In this last case, RNA
conformational changes have been determined by the use of MBs
that target specific RNA regions that become free for hybridization.
This usually occurs after binding of the metabolite, which induces
the subsequent RNA structural change on the ribozyme or ribos-
witch (Fig. 1c) [5, 6]. Thus, only when theMB is bound to its RNA
target, the probe structure unfolds and becomes fluorescent. On
the other hand, in order to study RNA chaperone activity, a more
direct approach by using a MB that mimics the regulatory RNA
hairpin targeted by a specific RNA-binding protein (RBP) has been
adopted [7, 8]. This strategy assumes that binding of the RNA
chaperone to the MB may cause a similar RNA conformational
rearrangement to the one occurring on the native RNA. Therefore,
the MB may act as a direct reporter of its own structural rearrange-
ment (Fig. 1d). We choose this approach to demonstrate that the
Fig. 1 Examples of different MB designs dedicated to (a) quantifying specific DNA or RNA molecules, (b)
analyzing the single-stranded DNA cleavage by specific nucleases [4], (c) studying the structural changes on
ribozymes and riboswitches [5, 6], or (d) determining the RNA chaperone activity on hairpin-like structures by
cold shock proteins (CSPs) [7–9]. In all cases, the MB switch turns on when the fluorophore (FAM) folds away
of the quencher (BHQ_1) due to the base-pairing of the MB with its specific target (a, c) or to the MB cleavage
or unfolding by the activity of an RNA-binding protein (b, d)
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RNA chaperone CspA of Staphylococcus aureus unfolds the RNA
hairpin present in the 50UTR of its own mRNA [9] (Fig. 2a). This
hairpin (ΔG ¼ 24.60 kcal/mol) is cleaved by endoribonuclease
III (RNase III) mainly at position G-53, generating a shorter cspA
mRNA version that is more efficiently translated than the unpro-
cessed mRNA [10]. CspA would repress its own expression by
unfolding the hairpin and thus antagonize the function of RNase
III [9].
Specifically, we designed a MB that comprised a 49-mer ssDNA
oligonucleotide, which included the central functional sequence of
the cspA 50UTR hairpin (ΔG ¼ 13.70 kcal/mol). A molecule of
fluorescein (FAM) and a Black Hole Quencher (BHQ_1) were
attached to the 50 and 30 ends, respectively (Fig. 2b). In the native
MB conformation, BHQ_1 efficiently quenched the fluorescence
from FAM, indicating that the designed MB accurately mimicked
the cspA 50UTR hairpin. In contrast, when the MB structure was
disrupted (separating FAM from BHQ_1) either by the presence of
the RNA chaperone CspA or by an increase in the temperature of
incubation, fluorescence emission was registered. The folded
Fig. 2 Molecular beacon (MB) design to study the CspA RNA chaperone activity on the RNA hairpin structure of
the cspA mRNA [9]. (a) The proposed RNA structure for the 50UTR of cspA is shown [10]. The U-rich motif
required for CspA interaction is highlighted in red. (b) The MB consisted of a 49-mer ssDNA oligonucleotide
labelled with the FAM fluorophore and the BHQ_1 quencher at its 50 and 30 ends, respectively [9]
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conformation of the MB could be efficiently restored (indicated by
the ceasing of fluorescence emission) either by adding Proteinase K,
which eliminated the chaperone activity by degrading CspA, or by
decreasing the temperature of incubation. The specificity of CspA
on the designed MB system was verified by the incubation of the
MB with an unrelated protein.
This strategy allowed us to demonstrate that CspA unfolded
the regulatory hairpin located at the cspA 50UTR and, thus, inter-
fered with cspAmRNA processing by RNase III. When CspA levels
were low, the cspA 50UTRRNA hairpin was targeted and cleaved by
RNase III. The resulting processed mRNA suffered a conforma-
tional change that favored CspA translation [10]. When CspA levels
rose, CspA decreased its own expression by unfolding the cspA
50UTR RNA hairpin to avoid RNase III cleavage [9] (Fig. 3).
Fig. 3 Schematic representation of the putative auto-regulatory mechanism modulating CspA expression as
previously described by Caballero and colleagues [9]. The 50UTR of the cspA mRNA forms a hairpin structure
that is cleaved by RNase III to enhance CspA translation when CspA levels are low [10]. When the
concentration of CspA inside the cell is high, the protein is able to interact with the hairpin structure through
a U-rich motif and unfold it. As a consequence, the cspA mRNA is not processed by RNase III and CspA
translation is decreased
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Here, we describe in detail the different steps that should be
followed to determine the RNA folding rearrangements caused by
the binding of any RBP by using a MB that mimics a natural target
(whose synthesis could be ordered from a regular oligonucleotide
supplier company). The protocol requires commonly available
equipment at a molecular biology research center. It is noteworthy
that, with slight modifications, this protocol may be adapted to test
(1) any DNA or RNA folding structure that allows close proximity
of BHQ_1 to FAM and that provides enough separation between
them when disrupted; (2) the activity of RBPs such as RNA cha-
perones, RNA helicases and ribonucleases that target and/or pro-
cess hairpin-like structures; and (3) the function of small regulatory
RNAs that produce conformational changes on hairpin-like struc-
tures of their mRNA targets.
2 Materials
Prepare all solutions using ultrapure water (prepared by purifying
deionized water to reach a sensitivity of at least 18 MΩ at 25 C)
and analytical grade reagents for use in molecular biology. Store
solutions at room temperature unless stated otherwise. Follow





2.1.1 Growth of Bacteria
Expressing GST-CspA
Fusion Protein
1. E. coli BL21 (DE3) harboring pGEX-6P-2::cspA (see Note 1).
2. Sterile material for bacterial growth: 10-, 100- and 1000-μL
pipette tips, test tubes, 2-L Erlenmeyer flasks, graduated cylin-
ders, 250-mL centrifuge tubes, petri dishes, 1.5-mL Eppen-
dorf tubes.
3. 100 mg/mL ampicillin stock solution sterilized by filtration.
Store at 20 C.
4. 40% Glucose solution sterilized by filtration.
5. Luria Bertani (LB) agar plates supplemented with 100 μg/mL
ampicillin.
6. Microbiological incubator at 37 C.
7. Luria Bertani (LB) medium sterilized by autoclave and supple-
mented with glucose and ampicillin to a final concentration of
1% and 100 μg/mL, respectively.
8. Shaking incubator at 37 C and 200 r.p.m.
9. Spectrophotometer.
10. Centrifuge with rotor for Eppendorf tubes.
11. 200 mg/mL Isopropyl-β-D-1-thiogalactopyranoside (IPTG)
stock solution, sterilized by filtration. Store at 20 C.
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12. Refrigerated centrifuge with rotor for 250-mL centrifuge
flasks.
13. Phosphate buffered saline (PBS): pH 7.3, 140 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 sterilized
by autoclave.
2.1.2 Bacterial Cell Lysis
and Recovery of Total
Protein Crude Extract
1. Sterile 15-mL and 50-mL conical tubes.
2. Sterile PBS pH 7.3 (see item 13 in Subheading 2.1.1).
3. 50 mg/mL Lysozyme stock solution sterilized by filtration.
Store at 20 C.
4. 10 mg/mL RNase A stock solution. Store at 20 C.
5. 100 mM Phenylmethanesulfonyl fluoride (PMSF) stock solu-
tion prepared in isopropanol. Store at 20 C (see Note 2).
6. Shaking incubator at 30 C and 200 r.p.m.
7. Branson sonifier 250 with microtip.
8. Centrifuge with a rotor for 50-mL tubes, which allows centri-
fugation at 16,000  g.
9. High speed centrifuge tubes.
10. 5 mg/mL DNase I stock solution prepared by dissolving
DNase I powder in 0.15 M NaCl.
11. 0.45 μm filters and 1.5-mL Eppendorf tubes.
12. 12% SDS-polyacrylamide gels.
13. 6 Sample buffer: 375 mM Tris–HCl pH 6.8, 9% SDS, 50%
glycerol, 9% β-mercaptoethanol and 0.03% bromophenol blue.
Store at 20 C.
14. Tris–glycine running buffer: 25 mM Tris, 192 mM glycine,
0.1% SDS.
15. Protein molecular weight marker. Store at 20 C.
16. Heating block.
17. Electrophoresis chamber for polyacrylamide gels.
18. Power supply.
19. Coomassie brilliant blue R250 solution.
20. Orbital shaker.
21. Destaining solution: 40% ethanol and 10% acetic acid in water.
22. Fixation solution: 10% ethanol and 3% glycerol in water.
2.1.3 Purification
of Recombinant CspA from
Total Protein Crude
Extracts
1. AKTAprime plus chromatography system.
2. GSTrap FF 5-mL column.
3. GSTrap FF 1-mL column.
4. HiPrep 16/60 Sephacryl S-100 HR column.
46 Pilar Menendez-Gil et al.
5. Ultrapure water, sterilized by autoclave and degassed.
6. 20% ethanol solution sterilized by autoclave and degassed.
7. Binding Buffer: degassed sterile PBS pH 7.3 (see item 13 in
Subheading 2.1.1).
8. PreScission Protease buffer: 50 mM Tris–HCl pH 7, 150 mM
NaCl, 1 mM EDTA, 1 mM DTT sterilized by autoclave and
degassed.
9. PreScission Protease.
10. PreScission Protease mix: mix 100 μL (200 units) of PreScis-
sion Protease with 4.9 mL of PreScission Protease buffer at
4 C.
11. 5-mL syringe with Luer tip.
12. 1.5-mL Eppendorf tubes and 15-mL conical tubes.
13. Elution buffer: 50 mM Tris–HCl pH 8, 10 mM reduced
glutathione sterilized by autoclave and degassed.
14. Gel Filtration buffer: 20 mM Tris–HCl pH 7.4,
500 mM NaCl.
15. Slide-A-Lyzer Dialysis Cassettes.
16. 0.22 μm filters.
17. CspA Storage buffer: 10 mM Tris–HCl pH 8, 1 mM EDTA,
50 mM potassium chloride and 10% glycerol.
18. Bio-Rad protein assay.
19. 96-well standard plates.
20. MultiSkan EX (Labsystems) or any other equivalent microplate
photometer.
2.2 Assessment




1. Molecular beacon mimicking the hairpin structure under study
(see Note 3).
2. Spectrophotometer equipped with a UV lamp (e.g.,
NanoDrop).
3. Recombinant RNA chaperone CspA (or protein of interest).
4. Bovine Serum Albumin (BSA) dissolved in CspA storage buffer
at the same concentration as the protein of interest (see Note
4).
5. TE buffer: 10 mM Tris–HCl pH 7.5 and 1 mM EDTA.
6. 96-well PCR plates suitable for the Real-Time PCR System
available. Plate is sealed with optically clear adhesive film (see
Note 5).
7. AriaMx Real-Time PCR System (Agilent Technologies) or any
other equivalent thermal cycler including an optical system able
to excite the FAM fluorophore and register the fluorescence
emission at different temperature incubation times.
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8. CspA storage buffer (see item 17 in Subheading 2.1.3).
9. 10 reaction buffer: 100 mMTris–HCl pH 7.5, 300 mMKCl,
200 mM NH4Cl, 15 mM DTT, 50 mM MgCl2 (see Note 6).
10. 4 U/μL Ribolock (see Note 7).
11. Proteinase K (Sigma) stock solution. Dissolved Proteinase K
powder in water to a final concentration of 20 mg/mL (see





3.1.1 Growth of Bacteria
Expressing the GST-CspA
Fusion Protein
1. Streak the E. coli BL21 (DE3) pGEX-6P-2::cspA strain in an
LB agar plate supplemented with 100 μg/mL ampicillin and
incubate at 37 C overnight.
2. Inoculate a colony of the previous culture into a sterile test tube
containing LB medium supplemented with 100 μg/mL ampi-
cillin and 1% glucose. Grow culture at 37 C and 200 r.p.m.
overnight.
3. Inoculate 500 μL of the bacterial preculture (1/1000 dilution
factor) into two sterile pre-warmed 2-L Erlenmeyer flasks con-
taining 500 mL of LBmedium supplemented with 100 μg/mL
ampicillin and 1% glucose. Mix and incubate the cultures at
37 C and 200 r.p.m. until an optical density (OD600nm) of 0.5
is reached.
4. Induce the expression of CspA by addition of IPTG to a final
concentration of 0.4 mM. Save 1 mL of culture of one of the
flasks and centrifuge it for 3 min at 18,000  g. Store the
bacterial pellet at 20 C. This aliquot sample corresponds to
the pre-induction control (see Note 9). Resume bacterial
growth for another 5 h at 37 C and 200 r.p.m.
5. Save 1 mL of culture of one of the flasks and centrifuge it for
3 min at 18,000 g. Store the bacterial pellet at20 C (post-
induction control) (seeNote 9). Harvest the rest of the cultures
in 250-mL tubes and centrifuge for 10 min at 5000  g (see
Note 10). Discard the supernatant and resuspend the pellets in
1 volume of PBS pH 7.3. Repeat the centrifugation step,
discard the supernatant and store the bacterial pellets at
80 C (see Note 11).
3.1.2 Bacterial Cell Lysis
and Recovery of Total
Protein Crude Extract
1. Thaw the bacterial pellets, resuspend them in 25 mL PBS
pH 7.3 in 50-mL conical tubes (per pellet) and add lysozyme,
RNase and PSMF to a final concentration of 1 mg/mL, 10 μg/
mL, and 1mM, respectively. Incubate the samples for 30min at
30 C and 200 r.p.m.
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2. Sonicate the samples on ice as follows: 3 cycles of 30 s power
4, 2 cycles of 30 s power 5. Leave the samples on ice for 1 min
in between cycles.
3. Centrifuge the samples at 16,000  g for 30 min at 4 C (see
Note 10). Transfer the supernatant (soluble fraction) to new
tubes and store the pellet at20 C. Pellets (insoluble fraction)
contain inclusion bodies (IB), and constitute the IB control (see
Note 9).
4. Supplement the soluble fraction with DNase I and RNase A to
a final concentration of 10 μg/mL and 5 μg/mL, respectively,
and incubate on ice for 30 min. Store 50 μL of the sample at
20 C (pre-filtered soluble fraction control) (see Note 9).
5. Filter the soluble fraction using a 0.45 μm filter whilst on ice
(see Note 12). Store 50 μL of the sample at 20 C (post-
filtered soluble fraction control) and the rest of the soluble
fraction at 20 C (see Note 9).
6. Mix aliquots of the different control samples (pre-induction
control, post-induction control, IB control, pre-filtered soluble
fraction and post-filtered soluble fraction), collected in the
previous steps (see Note 9), with 6 sample buffer to a final
concentration of 1. Denature mixtures at 95 C for 5 min and
load them in a polyacrylamide gel (a Molecular Weight Marker
should be included) (see Note 13). Run the gel with 1
running buffer at 130 V until the front reaches the bottom of
the gel (see Note 14).
7. Stain the gel with Coomassie blue for at least 4 h at room
temperature on an orbital shaker. Destain the gel with several
washes of destaining solution at room temperature and shak-
ing. Once protein bands are visible and the background level is
low, incubate the gel with fixing solution for 15 min at room
temperature and shaking. Optimal results are reached when
most of the GST-CspA fusion protein appears in the soluble
fraction and not in the inclusion bodies fraction (see Note 15).
3.1.3 Purification of the
Recombinant CspA Protein
1. Thaw the post-filtered soluble fraction and purify the
GST-CspA fusion protein with the use of a GSTrap FF 5-mL
column and an AKTAprime plus chromatography system, fol-
lowing the recommendations of the manufacturer.
2. Clean the system with 20% ethanol and ultrapure water.
3. Connect the column to the AKTAprime plus system “drop to
drop” to avoid introducing air into the column. Equilibrate the
column with 25 mL of binding buffer at a flow rate of 5 mL/
min.
4. Apply the sample at a flow rate of 0.2 mL/min (see Note 16).
Molecular Beacons to Assess RNA Chaperone Activity 49
5. Wash the column with 50 mL of binding buffer at a flow rate of
5 mL/min.
6. Equilibrate the column with 50 mL of PreScission Protease
buffer at a flow rate of 5 mL/min and disconnect the column
from the AKTAprime plus chromatography system.
7. Prepare the PreScission Protease mix at 4 C and load it manu-
ally onto the column using a syringe at a flow rate of 1 mL/
min. Seal the column with the top and bottom stop plugs and
incubate overnight at 4 C.
8. Connect a GSTrap FF 1-mL column to the AKTAprime plus
system and equilibrate it with 5 mL of PreScission Protease
buffer at a flow rate of 1 mL/min.
9. Place the GSTrap FF 5-mL column on top of the GSTrap FF
1-mL column. This tandem column scheme acts as a filter to
capture any released cleaved GST proteins, uncleaved
GST-tagged proteins and unbound PreScission Protease.
Elute CspA with 15 mL of PreScission Protease buffer at a
flow rate of 1 mL/min. Collect 1 mL fractions containing the
CspA protein and place them on ice.
10. Elute the GST and GST-PreScission Protease from the col-
umns with 30 mL of elution buffer at a flow rate of 1 mL/
min. Clean the system and columns with ultrapure water and
20% ethanol and remove columns from the system.
11. Dialyze the CspA fractions against Gel Filtration buffer using a
Slide-A-Lyzer Dialysis Cassette overnight at 4 C. Collect
CspA from the Dialysis Cassette and filter the solution using
a 0.22 μm filter. Keep the CspA sample on ice until its purifica-
tion by size exclusion chromatography.
12. Connect a HiPrep 16/60 Sephacryl S-100 HR Column (see
Note 17) to the AKTAprime plus system “drop to drop” to
avoid introducing air into the column. Equilibrate the column
with 60 mL of ultrapure water at a flow rate of 0.5 mL/min
and then with 240 mL of Gel Filtration buffer at a flow rate of
1 mL/min.
13. Inject the CspA sample into the column and run it with
120 mL of Gel Filtration buffer at a flow rate of 0.5 mL/
min. Collect 3 mL fractions and place them on ice.
14. Clean the column with 480 mL of ultrapure water and 480 mL
of 20% ethanol at a flow rate of 1 mL/min. Remove the
column from the system and clean the system with ultrapure
water and 20% ethanol.
15. To select fractions containing CspA, mix an aliquot of each
peak fraction with sample buffer 6 and perform a 12% PAGE
as described above.
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16. Load the CspA selected fractions into a Slide-A-Lyzer Dialysis
Cassette and dialyze against CspA Storage buffer overnight at
4 C.
17. To assess protein purity, mix an aliquot of the recombinant
CspA chaperone with sample buffer 6 and perform a 12%
SDS-polyacrylamide gel electrophoresis (PAGE) as described
above.
18. Determine the recombinant protein concentration by the
Bio-Rad protein assay.
3.2 Assessment






The success of this assay lies in an adequate MB design, which is
based on two main principles: (1) the presence of an RNA structure
targeted by the RNA chaperone under study and (2) fluorescence
quenching exerted by a quencher dye (e.g., BHQ_1) on a fluor-
ophore (e.g., FAM), which occurs when both molecules are in close
proximity to one another. Additionally, the selected RNA structure
must keep the quencher close enough to the fluorophore at the
working temperature (switch OFF). MB mimicking hairpin-like
structures have been shown to comply these criteria before
[7–9]. Likewise, alternative MB conformations can be tested
according to the characteristics of the protein of interest. Having
decided the MB configuration, the synthesis of the labelled probe
may be ordered to any oligonucleotide supplier (see Note 18).
Based on the binding capacity of the CspA protein and the stability
and cost of the probe, we decided to use single-stranded DNA
instead of RNA oligonucleotides (see Note 19).
3.2.2 Testing
the Effectiveness
of the Designed MB
and Setup of the Working
Conditions
Before assessing if the RNA chaperone is able to unwind the MB
structure, the effectiveness of the designed MB must be tested
following two main criteria. On the one hand, no fluorescence
emission should be detected when the MB is in an OFF state. On
the other hand, maximum fluorescence levels should be registered
when the MB is completely unfolded (ON state). In other words, a
MB design will be appropriate when a large ON/OFF fluorescence
ratio is detected. Incubating different MB concentrations at
increasing temperatures (that denature the oligonucleotide and
open the structure leading to FAM fluorescence emission) helps
determining both the background fluorescence (see Note 20) and
the lowest quantity of oligonucleotide needed to obtain good
fluorescence levels when the MB is in an ON state (see Note 21).
To test if the MB design was successful, proceed as follows:
1. Dissolve the MB in TE buffer to obtain a concentration of
100 μM, following the manufacturer recommendations (see
Note 22). Concentration of the MB should be corroborated
with a spectrophotometer (e.g., NanoDrop).
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2. Program the AriaMx thermal cycler to incubate the MB sam-
ples as follows: 37 C, 5 min; 45 C, 5 min; 55 C, 5 min; and
65 C during 5 min (see Note 23). Register the emission of
FAM fluorescence every minute.
3. Make serial dilutions of the MB in an optical 96-well plate as
indicated in Table 1, which shows mixtures of the components
to analyze different concentrations of the MB. Triplicates are
highly recommended.
4. Seal the plate with an optically clear adhesive film (see Note 5)
and load it into the thermal cycler. Start the incubation
program.
5. Once the incubation time is finished, plot the obtained fluores-
cence signals in function of the MB concentration at the differ-
ent temperatures. If replicates are used, plot the means of the
fluorescence signals. The instrument background signal should
be previously subtracted. Figure 4 shows an example of the
results obtained with the MB designed for the analysis of
S. aureus CspA activity [9] (Fig. 4). In this example, when the
MB was incubated at 55 C and 65 C, fluorescence emission
was registered, indicating that the MB was in an ON state.
These fluorescence levels were directly proportional to the
MB concentration. In contrast, when the MB was incubated
at 37 C and 45 C, the fluorescence values were close to those
of the background confirming that the MB was in an OFF
configuration. This experiment validated the functionality of
the designed MB (see Note 24).
Table 1
Preparation of dilution mixes for testing MB effectivenessa
MB concentration (pmol)
0 0.5 1 2 5 10 15 20
MB 10 μM – – – – 0.5 1 1.5 2
MB 1 μM – 0.5 1 2 – – – –
CspA storage bufferb 12.5 12 11.5 10.5 12 11.5 11 10.5
10 reaction buffer 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
Ultrapure water 10 10 10 10 10 10 10 10
Final volume 25 μL
aVolumes of each reactive are indicated in μL
bSince the CspA protein is diluted in CspA storage buffer, the MB effectiveness test is performed including this buffer
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3.2.3 Determination
of the RNA Chaperone
Activity Using
the Designed MB
1. Based on the data obtained from the MB effectiveness test,
select the lowest MB concentration that gives a good ratio
between the fluorescence and background signals (see
Note 21).
2. Program the AriaMx thermal cycler to incubate the MB sam-
ples as follows: 37 C, 5 min; PAUSE, 37 C, 15 min; PAUSE,
37 C, 30 min; 65 C, 10 min; STOP (Table 2). Register the
fluorescence emission every minute (see Note 25).
3. Prepare an optical 96-well plate including the reaction mixes as
indicated in Table 2 (see Note 26). Note that the CspA and
BSA proteins should be added later.
4. Seal the plate with adhesive film (see Note 5) and load it into
the thermal cycler. Start the incubation program.
5. At the first pause of the incubation program, pull out the
96-well plate from the thermal cycler, remove the adhesive
film and add the appropriate quantity of CspA and BSA.
Re-seal the plate with a new adhesive film. This step must be
performed swiftly.
6. Reintroduce the plate into the thermal cycler and continue the
incubation at 37 C during 15 min. Register the fluorescence
emission every minute.
7. During the second incubation pause, pull out the plate, remove
the adhesive film and add 10 μL of proteinase K (20 mg/mL).
Re-seal the plate with a new adhesive film. This step must be
performed swiftly.
8. Reintroduce the plate into the thermal cycler and continue the
incubation for 30 min at 37 C and then increase the tempera-
ture up to 65 C during 10 min. Register fluorescence emission
Fig. 4 Test of the molecular beacon functionality. Different concentrations of the
MB mimicking the hairpin structure located at the 50UTR of the cspA mRNA were
incubated at different temperatures and fluorescence emission was registered.
The experiment was carried out using the AriaMx thermal cycler
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Table 2
Determination of RNA chaperone activity: preparation of reaction mixesa
Samplesb
1 2 3 4 5 6 7 8
MB tube labelling  + + + + + + +
CspA tube labelling   + + +   
BSA tube labelling      + + +
Water (Vf: 100 μL) 39 38 38 38 38 38 38 38
CspA storage buffer 50 50 30 15  30 15 
10 reaction buffer 10 10 10 10 10 10 10 10
MB 1 μM  1 1 1 1 1 1 1
Ribolock 4 U/μL 1 1 1 1 1 1 1 1
Seal the plate with adhesive film
Incubate 37 C—5 min
Register fluorescence emission every minute
PAUSE incubation programc
CspA stock (~200 μM)   20 35 50   
BSA stock (~200 μM)      20 35 50
Re-seal the plate with adhesive film
Incubate 37 C—15 min
Register fluorescence emission every minute
PAUSE incubation program
Proteinase K 20 mg/mL 10 10 10 10 10 10 10 10
Re-seal the plate with adhesive film
Incubate 37 C—30 min
Incubate 65 C—10 min
Register fluorescence emission every minute
Collect the fluorescence data from AriaMx thermal cycler
Plot the data accordingly
aVolumes of each reactive are indicated in μL
bReplicates of samples should be included
cIf the thermal cycler software allows it, the entire incubation protocol can be pre-programed including the
corresponding PAUSE times
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every minute. Once the incubation program is finished, collect
the result data sheet.
9. Plot the obtained data subtracting the background fluores-
cence levels. If the experiments work as expected, fluorescence
emission should be registered after addition of the RNA chap-
erone. This fluorescence should disappear after treatment with
Proteinase K, showing the specificity of the reaction. Finally,
increasing the temperature at 65 C should lead to maximum
levels of fluorescence, indicating that the MB remains func-
tional through the course of the experiment. Logically, in the
negative controls, no fluorescence emission should be detected
until the last step, when temperature is raised (e.g., see ref. 9).
4 Notes
1. Although we purified the RNA chaperone CspA from E. coli
using the glutathione S-transferase (GST) gene fusion system,
any other recombinant purification alternative can be used for
your protein of interest. We fused the cspA coding sequence to
the GST gene in the pGEX-6P-2 plasmid. This allowed the
convenient site-specific cleavage by the PreScission Protease
between the GST domain and CspA at low temperature, mini-
mizing the degradation of the protein of interest. Additionally,
it provided the recovery of the recombinant CspA protein with
only a few extra amino acids in its sequence (for details about
the construction of this strain see ref. 9). The fact that the
PreScission Protease was engineered with a GST tag, permitted
an on-column cleavage so that the GST moiety of the tagged
protein and the PreScission Protease itself remained bound to
the Glutathione Sepharose column. Thus, at the end of the
procedure CspA was not contaminated with the protease.
2. PMSF is unstable in the presence of water. A stock solution
should be prepared in anhydrous isopropanol or anhydrous
absolute ethanol.
3. Our designed MB consisted of a 49-mer single-stranded DNA
oligonucleotide, which was synthetized and labelled at its
extremes with the 6-FAM molecule and Black Hole Quencher
(BHQ_1) by the Integrated DNA technologies company. This
length was enough to include the functional part of the RNA
hairpin (Fig. 2).
4. We used bovine serum albumin (BSA), a protein without
capacity to bind nucleic acids, as a negative control. Any alter-
native protein lacking DNA/RNA binding domains can also
be used.
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5. We preferred to seal the 96-well plates with adhesive film
because removing it and re-sealing the plates is faster than
using flat caps. A quick sealing helps registering fluorescence
emission sooner, after the RNA chaperone is added to the MB
solution.
6. Storage of the 10 reaction buffer will require it to be prepared
without DTT. DTT should be added just before use.
7. Any alternative RNase inhibitor can be used. If ssDNA is used
as the backbone of the MB, RNase inhibitors are not required.
8. To demonstrate the specificity of chaperone activity, proteinase
K (or any alternative protease) may be included to degrade the
protein under study. This should eliminate the RNA chaperone
activity and restore the MB folding. If fluorescence is not
quenched again after Proteinase K treatment (in other words,
the MB cannot be refolded), it might indicate a contamination
of the RNA chaperone solution with nucleases that affect the
MB integrity.
9. It is important to collect samples at various steps during the
purification procedure to monitor the yield of the recombinant
protein. Comparison of these control samples helps evaluating
if (1) the induction of the recombinant protein expression is
adequate (pre-induction vs post-induction control), (2) the
recombinant protein is present in the soluble and/or the insol-
uble fraction (IB control vs soluble fractions), and (3) the
recombinant protein is lost during the step of sample clearance
by filtration (pre-filtered vs post-filtered soluble fractions).
10. Centrifuge should be pre-cooled before use.
11. Bacterial pellets can be stored at 80 C for several days.
12. We recommend the use of filters with a pore size of 0.45 μm
instead of 0.2 μm to avoid filter saturation.
13. Pre-cast or custom-made gels may be used with the appropriate
percentage of acrylamide according to the protein of interest
(we used 12% PAGE).
14. Adjust voltage of the electrophoresis system accordingly.
15. If the protein of interest is not in the soluble fraction, bacterial
growing conditions should be modified to force its solubiliza-
tion. Alternatively, protein purification methods from inclusion
bodies may be applied.
16. Due to the slow binding kinetics between GST and glutathi-
one, it is very important to keep the flow rate as low as possible
during sample application for maximum binding capacity.
17. The column used in this protocol is specific for separating
proteins with a small size. If the RNA chaperone of interest
has a bigger size, the column should be changed accordingly.
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18. Some oligonucleotide supplier companies limit the synthesis of
labelled oligonucleotide probes to 50 nucleotides (nt). In our
design, the functional RNA hairpin region could be included in
an oligonucleotide probe smaller than 50 nt. For larger regu-
latory structures, the synthesis of a MB may prove more chal-
lenging. This problem could be solved by dividing the MB
synthesis into two shorter oligomers that can afterwards be
ligated as previously described [7].
19. The reason for using a labelled DNA oligonucleotide as a MB is
that it has been proven that CSPs can bind ssDNA as efficiently
as RNA molecules [11]. Nevertheless, testing other
RNA-binding proteins may require synthesis of
RNA-based MBs.
20. If the region of the RNA structure under study is not strong
enough to maintain the MB beacon in an OFF state, the basal
level of fluorescence might be too high to obtain reliable results
once the RNA chaperone is added.
21. Sometimes the quantity or the concentration of the chaperone
under study can be limited. We recommend using the lowest
concentration of the MB that gives good fluorescent levels in
an ON state. This will help saving RNA chaperone sample.
22. The fluorophores of the MB are sensitive to the light; there-
fore, keep the stock and any other dilutions wrapped in alumi-
num foil and protect them from exposure to light to maintain
their integrity.
23. The selected temperature might vary depending on the melt-
ing temperature of the MB structure.
24. If the control of the MB functionality does not show clear
differences on the fluorescence signals between ON and OFF
states, and/or the fluorescence background is too high, the
MB should be redesigned.
25. The entire incubation protocol to be carried out with the
AriaMx thermal cycler (or any equivalent equipment) can be
programed from the beginning, including the corresponding
pause times required to add the different components of the
reactions.
26. Volumes of each reactive should be adjusted according to the
concentration of the RNA chaperone.
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